Comparison of the effect of fluoxetine and citalopram on motor recovery after ischemic stroke, single-blind clinical trial

The efficacy comparison of fluoxetine and citalopram on motor recovery after ischemic stroke: single-blind placebo-controlled randomized clinical trial

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20210307050617N1

Enrollment

Registered

2021-03-27

Start date

2021-03-26

Completion date

Unknown

Last updated

2021-04-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ischemic stroke. Cerebral infarction, unspecified

Interventions

Intervention 1: Intervention group 1: The first intervention group is group A, which has 30 patients.They are given fluoxetine capsules made by Aria Company at a dose of 20 mg daily for three months,

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Age over 18 years Hemiparesis or hemiplegia after the first ischemic stroke in 24 hours A score greater than 2 NIHSS scale motion items

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Evaluate the rate of improvement in motor function after receiving the drug after one, two and three months. Timepoint: The patient's motor function is measured every month. The study time on each case is 90 days. Method of measurement: Using the NIHSS scale motion item.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Payam Saadat

Babol University of Medical Sciences

sepanta1968@yahoo.com+98 11 3219 2034

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026